Compounds > diallyl disulfide
Page last updated: 2024-08-22

diallyl disulfide and ER-Negative PR-Negative HER2-Negative Breast Cancer

diallyl disulfide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chakraborti, A; Kundrapu, DB; Malla, R; Marni, R1
Chintamaneni, PK; Nandha Kumar, S; Pindiprolu, SKSS; Siddhartha, VT; Tummala, S1
Bauer, D; Darling-Reed, S; Mazzio, E; Oriaku, E; Soliman, KF; Taka, E; Womble, T1
Huang, J; Li, H; Peng, W; Qiu, Z; Ren, G; Wan, J; Xiang, T; Yang, B; Zhang, L1

Other Studies

4 other study(ies) available for diallyl disulfide and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells.
    Journal of ethnopharmacology, 2022, Oct-05, Volume: 296

    Topics: Allyl Compounds; Antioxidants; Apoptosis; Cell Line, Tumor; Disulfides; Garlic; Humans; Paclitaxel; Reactive Oxygen Species; Sulfides; Triple Negative Breast Neoplasms

2022
RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:2

    Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Cell Survival; Disulfides; Drug Liberation; Gene Expression Regulation, Neoplastic; Humans; Lipids; Nanoparticles; Receptor for Advanced Glycation End Products; Triple Negative Breast Neoplasms

2018
Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.
    Anticancer research, 2014, Volume: 34, Issue:6

    Topics: Adipokines; Allyl Compounds; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Chemokine CCL2; Disulfides; Enzyme-Linked Immunosorbent Assay; Female; Garlic; Humans; Protein Array Analysis; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2014
Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Molecular nutrition & food research, 2015, Volume: 59, Issue:6

    Topics: Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Garlic; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2015